Cellectar Biosciences, Inc. (CLRB)
↓ Download CSVKey ratios (FY2025)
-255.2%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$22.98M | -$51.78M | -$38.96M | -$28.81M | -$24.13M | -$15.29M | -$14.18M | -$13.33M | -$13.60M | -$9.45M |
| Net Income | -$21.79M | -$44.58M | -$42.77M | -$31.79M | -$24.12M | -$15.09M | -$14.09M | -$13.24M | -$13.56M | -$6.18M |
| EPS (Diluted) | $-8.35 | $-41.89 | $-3.50 | $-4.51 | $-4.35 | $-1.84 | — | — | — | — |
| Total Assets | $14.98M | $25.47M | $12.08M | $21.59M | $37.20M | $58.66M | $12.25M | $15.05M | $12.87M | $15.32M |
| Total Liabilities | $5.06M | $9.80M | $25.85M | $12.05M | $4.16M | $3.86M | $3.19M | $1.79M | $2.12M | $1.78M |
| Shareholders' Equity | $8.54M | $14.29M | -$15.16M | $8.15M | $29.06M | $54.79M | $9.06M | $13.26M | $10.75M | $13.54M |
| Cash & Equivalents | $13.20M | $23.29M | $9.56M | $19.87M | $35.70M | $57.17M | $10.61M | $13.26M | $10.01M | $11.44M |
| Operating Cash Flow | -$23.12M | -$47.58M | -$32.38M | -$25.22M | -$22.57M | -$13.93M | -$11.69M | -$11.44M | -$11.02M | -$8.28M |
| Capital Expenditures | $5.9K | $104.2K | $864.0K | $226.0K | $141.4K | $62.4K | $24.5K | $385.0K | $346.7K | $72.3K |
| Shares Outstanding | 4.24M | 1.54M | 20.74M | 9.39M | 6.11M | 45.44M | 9.39M | 4.73M | 1.67M | 10.37M |